Centene vs Humana
Centene reported revenue of $194.8 billion in fiscal 2025, 1.5 times Humana's $129.7 billion in fiscal 2025. Centene's revenue grew 19.4% in its latest year, and Humana's grew 10.1%. Centene had an operating margin of -3.9%, against 2.1% at Humana. Free cash flow was $4.3 billion at Centene and $375 million at Humana.
Side by side
| Centene | Humana | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $194.8B | $129.7B |
| Revenue growth | 19.4% | 10.1% |
| Revenue growth a year, last 5 years | 11.9% | 10.9% |
| Gross margin | — | — |
| Operating margin | −3.9% | 2.1% |
| Net margin | −3.4% | 0.9% |
| Free cash flow | $4.3B | $375M |
| Free cash flow margin | 2.2% | 0.3% |
| Return on capital | −26.4% | 25.7% |
| Net debt to EBITDA | — | −2.2x |
| Dividends and buybacks | $475M | $581M |
| Change in diluted share count | −5.8% | −0.0% |
| Last close | $68.03 | $417.22 |
| P/E at the last close | — | 44.5× |
| Insider trades, last 12 months | sold $14.6 million | bought $150,020, sold $0 |
| Piotroski F-score | 5 of 8 | 5 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CenteneHumana
Operating margin
Percent of revenue
CenteneHumana
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CenteneHumana